DCM
NVO

DGS Capital Management’s Novo Nordisk NVO Stock Holding History

DGS Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17M Buy
31,948
+667
+2% +$31.6K 0.19% 99
2025
Q4 		$1.59M Buy
31,281
+1,939
+7% +$99.2K 0.27% 66
2025
Q3 		$1.63M Sell
29,342
-9,698
-25% -$568K 0.3% 57
2025
Q2 		$2.69M Sell
39,040
-313
-0.8% -$21.3K 0.56% 27
2025
Q1 		$2.73M Sell
39,353
-1,442
-4% -$119K 0.72% 23
2024
Q4 		$3.51M Sell
40,795
-1,208
-3% -$131K 0.88% 17
2024
Q3 		$5M Sell
42,003
-381
-0.9% -$50.8K 1.36% 10
2024
Q2 		$6.05M Sell
42,384
-504
-1% -$66.8K 1.7% 9
2024
Q1 		$5.51M Buy
42,888
+1,151
+3% +$137K 1.56% 9
2023
Q4 		$4.32M Sell
41,737
-582
-1% -$57.6K 1.66% 7
2023
Q3 		$3.85M Buy
42,319
+445
+1% +$39.2K 1.88% 7
2023
Q2 		$3.39M Sell
41,874
-112
-0.3% -$9.15K 1.69% 7
2023
Q1 		$3.34M Buy
41,986
+12
+0% +$851 1.86% 7
2022
Q4 		$2.84M Sell
41,974
-598
-1% -$35.1K 1.86% 7
2022
Q3 		$2.12M Buy
42,572
+2,378
+6% +$127K 1.42% 8
2022
Q2 		$2.24M Sell
40,194
-672
-2% -$37.3K 1.81% 8
2022
Q1 		$2.27M Buy
40,866
+5,242
+15% +$269K 1.39% 8
2021
Q4 		$2M Buy
+35,624
New +$1.93M 1.24% 9

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

DGS Capital Management's NVO Position: Q1 2026 in Review

DGS Capital Management increased its Novo Nordisk (NVO) stake by 2.1% in Q1 2026, buying an estimated $31.6K and bringing the position to 31,948 shares worth $1.17M. The position accounts for 0.19% of the portfolio, ranked #99.

DGS Capital Management first reported a position in NVO in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.05M in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • DGS Capital Management held 31,948 shares of Novo Nordisk worth $1.17M as of Q1 2026.
  • DGS Capital Management bought 667 Novo Nordisk shares in Q1 2026, an estimated $31.6K.
  • Novo Nordisk made up 0.19% of DGS Capital Management's portfolio in Q1 2026, its #99 holding.
  • DGS Capital Management first reported a position in Novo Nordisk in Q4 2021 and has held it in 18 quarters since.
  • DGS Capital Management's Novo Nordisk position peaked at $6.05M in Q2 2024.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.